Evidence map›Paper›PMID 40875115›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Production and Purification of SUMO-UBC9 and SUMO-RANGAP1

El Hadji Cisse, Stéphane Goffinont, Bertrand Castaing, Marcin J Suskiewicz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

El Hadji CisseCentre de Biophysique Moléculaire (CBM), UPR 4301, CNRS, affiliated with Université d'Orléans, Orléans, France.
Stéphane GoffinontCentre de Biophysique Moléculaire (CBM), UPR 4301, CNRS, affiliated with Université d'Orléans, Orléans, France.
Bertrand CastaingCentre de Biophysique Moléculaire (CBM), UPR 4301, CNRS, affiliated with Université d'Orléans, Orléans, France.
Marcin J SuskiewiczCentre de Biophysique Moléculaire (CBM), UPR 4301, CNRS, affiliated with Université d'Orléans, Orléans, France. marcin.suskiewicz@cnrs-orleans.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMOylation is a post-translational modification catalyzed by a multi-step enzymatic cascade. To gain structural biology insights into the last step of this process, where SUMO is transferred from a SUMO~UBC9 molecule onto a substrate, stable complexes with SUMO covalently linked to UBC9, the substrate, or both are essential. Here, building on previously published approaches and our experience, we describe detailed protocols for the generation of a simple stable mimetic of human SUMO~UBC9, as well as a stably SUMOylated version of a model substrate, the C-terminal domain of RANGAP1. Both of these molecules can be used to reconstitute noncovalent complexes with a fragment of a SUMO E3 ligase for biophysical and structural analysis.

Indexed as

GTPase-Activating ProteinsSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinUbiquitin-Conjugating EnzymesHumansProtein Processing, Post-TranslationalSumoylationUbiquitin-Conjugating Enzyme UBC9GTPase-Activating ProteinsRANGAP1 protein, humanSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9Preparative scale production of SUMOylated proteinsProtein SUMOylationRANGAP1Stable thioester mimeticsSUMOUBC9

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.